Acute Mesenteric Ischemia – Thrombolysis of SMA / Celiac Artery

Acute mesenteric ischemia (AMI) is a life-threatening condition characterized by a sudden reduction in blood flow to the intestines, leading to ischemia and potential bowel necrosis. Prompt diagnosis and treatment are critical to prevent severe complications and improve survival rates. One of the advanced treatment modalities for AMI caused by arterial thrombosis or embolism in the superior mesenteric artery (SMA) or celiac artery is thrombolysis — a minimally invasive procedure aimed at dissolving the clot and restoring blood flow. This article provides a comprehensive overview of AMI, focusing on thrombolysis of the SMA and celiac artery, highlighting its importance, procedure, and outcomes.

Anatomy / Background

The mesenteric circulation primarily involves the celiac artery, superior mesenteric artery (SMA), and inferior mesenteric artery (IMA), which supply blood to the gastrointestinal tract. The SMA is the most critical vessel for intestinal perfusion, supplying the small intestine, cecum, ascending colon, and part of the transverse colon. The celiac artery supplies the stomach, liver, spleen, and pancreas.

Acute mesenteric ischemia occurs when there is an abrupt interruption of blood flow through these arteries, most commonly the SMA, leading to ischemia of the bowel. The rapid loss of oxygen and nutrients causes mucosal injury, transmural infarction, and if untreated, bowel necrosis and perforation.

Causes / Etiology

The primary causes of acute mesenteric ischemia include:

Arterial embolism: Often originates from cardiac sources such as atrial fibrillation, valvular heart disease, or recent myocardial infarction. Emboli typically lodge in the SMA due to its angulation and size.
Arterial thrombosis:Usually occurs in patients with pre-existing atherosclerosis causing gradual narrowing of the SMA or celiac artery, which can suddenly thrombose.
Non-occlusive mesenteric ischemia (NOMI): Caused by splanchnic vasoconstriction due to low cardiac output states, shock, or vasopressor use.
Mesenteric venous thrombosis: Less common, involves thrombosis of the mesenteric veins leading to impaired venous outflow and ischemia.

Risk factors include advanced age, atrial fibrillation, heart failure, atherosclerosis, hypercoagulable states, recent surgery, and hypotension.

Symptoms / Clinical Presentation

Patients with acute mesenteric ischemia typically present with:

Severe abdominal pain: Often sudden, out of proportion to physical findings.
Nausea and vomiting
Diarrhea or bloody stools: May develop as ischemia progresses.
Abdominal distension
Signs of peritonitis: In advanced cases with bowel necrosis.
Systemic signs: Fever, tachycardia, hypotension, and shock in severe cases.

Early symptoms can be subtle, making diagnosis challenging.

Diagnosis

Diagnosis of AMI involves a combination of clinical suspicion, laboratory tests, and imaging:

Clinical examination: May reveal minimal tenderness initially despite severe pain.
Laboratory tests: Elevated white blood cell count, metabolic acidosis, elevated lactate levels, and D-dimer may support diagnosis but are nonspecific.
Imaging:
- CT angiography (CTA): The gold standard for diagnosis, showing arterial occlusion, bowel wall thickening, pneumatosis intestinalis, or portal venous gas.
- Mesenteric angiography: Both diagnostic and therapeutic, used especially when thrombolysis is planned.
- Ultrasound with Doppler: May detect flow abnormalities but less sensitive.

Contact Us

ARTERIAL

Treatment Options

Treatment depends on the cause, severity, and timing of diagnosis:

Supportive care: Fluid resuscitation, correction of acid-base imbalance, and broad-spectrum antibiotics.
Anticoagulation: Heparin to prevent further thrombosis.
Surgical intervention: Required if there is bowel necrosis or perforation; includes embolectomy, resection of necrotic bowel, or bypass.
Endovascular therapy: Includes catheter-directed thrombolysis, angioplasty, and stenting, especially for arterial thrombosis or embolism without bowel infarction.

Procedure Details: Thrombolysis of SMA / Celiac Artery

Catheter-directed thrombolysis is a minimally invasive procedure performed by interventional radiologists or vascular surgeons to dissolve thrombi in the SMA or celiac artery.

Steps involved:

Access: Usually via the common femoral artery under local anesthesia.
Catheterization: A guidewire and catheter are advanced under fluoroscopic guidance into the SMA or celiac artery.
Angiography: Contrast injection confirms the site and extent of occlusion.
Thrombolytic infusion: A catheter with multiple side holes is positioned within the thrombus, and thrombolytic agents such as tissue plasminogen activator (tPA) are infused.
Monitoring: Serial angiograms assess clot dissolution and restoration of blood flow.
Adjunctive procedures: Balloon angioplasty or stenting may be performed if underlying stenosis is present.
Completion: Once adequate reperfusion is achieved, the catheter is removed, and hemostasis is secured.

This procedure can be performed emergently and may avoid the need for open surgery if done early.

Postoperative Care / Rehabilitation

Intensive monitoring: Vital signs, abdominal examination, and laboratory parameters.
Anticoagulation: Continued to prevent re-thrombosis.
Nutritional support: Initially nil per os (NPO), progressing to enteral feeding as tolerated.
Imaging follow-up: Repeat CTA or Doppler ultrasound to assess vessel patency.
Physical rehabilitation: To restore strength and function after prolonged illness.
Management of underlying conditions: Control of atrial fibrillation, atherosclerosis, or hypercoagulable states.

Risks and Complications

Potential risks of thrombolysis include:

Bleeding: At the access site or systemic hemorrhage.
Reperfusion injury: Leading to bowel edema or systemic inflammatory response.
Incomplete clot dissolution: May require additional interventions.
Contrast-induced nephropathy
Allergic reactions to contrast agents
Bowel necrosis: If treatment is delayed.

Prognosis

The prognosis of AMI depends heavily on the timing of diagnosis and treatment. Early thrombolysis can significantly improve survival by restoring blood flow and preventing bowel infarction. However, mortality rates remain high, ranging from 50% to 70% in untreated or late-treated cases. Prompt intervention and multidisciplinary care are essential for favorable outcomes.

When to See a Doctor

Seek immediate medical attention if you experience:

Sudden, severe abdominal pain, especially if disproportionate to physical findings.
Persistent nausea, vomiting, or bloody stools.
Signs of shock such as dizziness, rapid heartbeat, or fainting.
History of atrial fibrillation or cardiovascular disease with new abdominal symptoms.

Early evaluation can be lifesaving.

Conclusion

Acute mesenteric ischemia is a critical vascular emergency requiring high clinical suspicion and rapid intervention. Thrombolysis of the superior mesenteric or celiac artery offers a minimally invasive option to restore intestinal blood flow and reduce the need for extensive surgery. Understanding the anatomy, causes, clinical presentation, and treatment options is vital for timely diagnosis and management. If you or someone you know experiences symptoms suggestive of AMI, immediate consultation with healthcare professionals is imperative to improve outcomes and save lives.

Explore more:

Chronic Mesenteric Ischemia – SMA / Celiac Artery Stenting

Acute Mesenteric Ischemia – Thrombolysis of SMA / Celiac Artery